$LYEL 8-K SEC Filings

Filed On	Filing
10 Sep 2026	8-K: Other Events Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
06 Aug 2026	8-K: Results of Operations and Financial Condition
15 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Results of Operations and Financial Condition
12 Mar 2026	8-K: Results of Operations and Financial Condition
09 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
08 Dec 2025	8-K: Other Events
05 Dec 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
12 Nov 2025	8-K: Results of Operations and Financial Condition
10 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
03 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation
16 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation
12 Aug 2025	8-K: Results of Operations and Financial Condition
25 Jul 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
26 Jun 2025	8-K: Unregistered Sales of Equity Securities
17 Jun 2025	8-K: Other Events
09 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation
28 May 2025	8-K: Material Modification to Rights of Security Holders
21 May 2025	8-K: Submission of Matters to a Vote of Security Holders
13 May 2025	8-K: Results of Operations and Financial Condition

Comments